You have 9 free searches left this month | for more free features.

Condition

Advanced Malignancies (1)

Melanoma (1)

Metastatic Cancer (1)

Pruritis (1)

Solid Tumors (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Incyte Corporation (1)

Massachusetts General Hospital (1)

Washington University School of Medicine (1)

Collaborator

Incyte Corporation (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

incb039110

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Melanoma Trial in Boston (Trametinib, Dabrafenib, INCB039110)

Active, not recruiting

Melanoma

Trametinib
+2 more

Boston, Massachusetts

Massachusetts General Hospital

Nov 1, 2021

Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in United States (INCB052793, gemcitabine, nab-paclitaxel)

Terminated

Has Results

Solid Tumors
+2 more

INCB052793
+10 more

Birmingham, Alabama
+13 more

Apr 6, 2020

Pruritis Trial (INCB039110)

Withdrawn

Pruritis

INCB039110

(no location specified)

May 10, 2019